Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Durr

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Immunopharmacology|January 1, 1990
Generation of tumoricidal effector cells with a novel potentiator: N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763)B S Wang, A L Lumanglas, Y I Lin, et al.
Cancer Research|May 1, 1979
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in miceR E Wallace, K C Murdock, R B Angier, et al.
International Journal of Immunopharmacology|January 1, 1988
Low molecular weight immunopotentiatorsV Ruszala-Mallon, Y I Lin, F E Durr, et al.
Cancer Investigation|January 1, 1986
Tissue deposition of bisantrene in B16 melanoma tumor-bearing miceG Nicolau, W H Wu, W McWilliams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|June 1, 1984
Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
International Journal of Cancer|November 15, 1970
Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cellsF E Durr, J H Monroe, R Schmitter, et al.
Cellular Immunology|April 15, 1987
Internalization and re-expression of antigens of human melanoma cells following exposure to monoclonal antibodyB S Wang, A L Lumanglas, J Silva, et al.
International Journal of Immunopharmacology|January 1, 1991
The mechanism of action of a synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738), in natural killer cell activation in animalsV Ruszala-Mallon, J Silva, A L Lumanglas, et al.
Immunology and Cell Biology|February 1, 1991
Depression of cell-mediated immunity in plasmacytoma-bearing miceV Ruszala-Mallon, J Silva, A L Lumanglas, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Immunopharmacology|January 1, 1990
Generation of tumoricidal effector cells with a novel potentiator: N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763)B S Wang, A L Lumanglas, Y I Lin, et al.
Cancer Research|May 1, 1979
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in miceR E Wallace, K C Murdock, R B Angier, et al.
International Journal of Immunopharmacology|January 1, 1988
Low molecular weight immunopotentiatorsV Ruszala-Mallon, Y I Lin, F E Durr, et al.
Cancer Investigation|January 1, 1986
Tissue deposition of bisantrene in B16 melanoma tumor-bearing miceG Nicolau, W H Wu, W McWilliams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|June 1, 1984
Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
International Journal of Cancer|November 15, 1970
Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cellsF E Durr, J H Monroe, R Schmitter, et al.
Cellular Immunology|April 15, 1987
Internalization and re-expression of antigens of human melanoma cells following exposure to monoclonal antibodyB S Wang, A L Lumanglas, J Silva, et al.
International Journal of Immunopharmacology|January 1, 1991
The mechanism of action of a synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738), in natural killer cell activation in animalsV Ruszala-Mallon, J Silva, A L Lumanglas, et al.
Immunology and Cell Biology|February 1, 1991
Depression of cell-mediated immunity in plasmacytoma-bearing miceV Ruszala-Mallon, J Silva, A L Lumanglas, et al.
Pageof 4